Organogenesis Holdings Inc (ORGO)
2.83
+0.08
(+2.91%)
USD |
NASDAQ |
Mar 28, 16:00
2.83
0.00 (0.00%)
After-Hours: 20:00
Organogenesis Holdings Cash from Operations (TTM): 30.92M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 30.92M |
September 30, 2023 | 28.10M |
June 30, 2023 | 16.82M |
March 31, 2023 | 18.37M |
December 31, 2022 | 24.86M |
September 30, 2022 | 35.01M |
June 30, 2022 | 57.40M |
March 31, 2022 | 64.69M |
December 31, 2021 | 61.98M |
September 30, 2021 | 67.24M |
June 30, 2021 | 48.26M |
March 31, 2021 | 21.45M |
December 31, 2020 | 5.466M |
September 30, 2020 | -24.15M |
June 30, 2020 | -38.47M |
Date | Value |
---|---|
March 31, 2020 | -41.25M |
December 31, 2019 | -33.53M |
September 30, 2019 | -44.53M |
June 30, 2019 | -62.07M |
March 31, 2019 | -65.74M |
December 31, 2018 | -60.64M |
September 30, 2018 | -46.23M |
June 30, 2018 | -23.40M |
March 31, 2018 | -7.824M |
December 31, 2017 | -3.493M |
September 30, 2017 | -5.341M |
June 30, 2017 | -5.197M |
March 31, 2017 | -4.997M |
December 31, 2016 | -4.871M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-65.74M
Minimum
Mar 2019
67.24M
Maximum
Sep 2021
8.542M
Average
19.91M
Median
Cash from Operations (TTM) Benchmarks
NovaBay Pharmaceuticals Inc | -5.026M |
Palatin Technologies Inc | -26.54M |
iBio Inc | -18.89M |
Theriva Biologics Inc | -17.82M |
Ampio Pharmaceuticals Inc | -10.55M |